American depositary receipts of European stocks were trading 0.32% lower at 138.73 on the Bank of New York Mellon Europe ADR Index on Monday.
In continental Europe, the gainers were led by pharmaceutical firm Oasmia Pharmaceutical ( OASM ), and biopharmaceutical company Ascendis Pharma ( ASND ), which rose 8.2% and 3.4% respectively. They were followed by biopharmaceutical company DB Technologies ( DBVT ), and biotech firm Zealand Pharma ( ZEAL ), which were up 3.2% and 1.4%.
The decliners in continental Europe were led by geophysical equipment company CGG ( CGG ), and VEON Com (VEON), a provider of communications services, which lost 2.2% and 2.3% respectively. Also declining were oil company Statoil (STO), and software firm SAP (SAP), which dropped 2.2 and 1.7%.
In the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX), which surged 6.2%, followed by Barclays Bank (BCS), which climbed 4.9%. Biopharmaceutical company Adaptimmune Therapeutics (ADAP), and communications company WPP (WPP) were up 3.0% and 2.1%.
The decliners in the UK and Ireland were led by biopharmaceutical firms Amarin (AMRN), and GW Pharmaceuticals (GWPH), which fell 3.5% each. Oil company Royal Dutch Shell (RDS), and mining company BHP Billiton (BBL) were off 3.3% and 2.9%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.